Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2018

Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0699EPD
  • |
  • Pages: 168
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Bariatric Surgery Devices-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Bariatric Surgery Devices-Medical Devices Pipeline Assessment, 2018" provides an overview of Bariatric Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bariatric Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bariatric Surgery Devices under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Bariatric Surgery Devices and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Bariatric Surgery Devices under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 9

2.1 Bariatric Surgery Devices Overview 9

3 Products under Development 10

3.1 Bariatric Surgery Devices-Pipeline Products by Stage of Development 10

3.2 Bariatric Surgery Devices-Pipeline Products by Segment 11

3.3 Bariatric Surgery Devices-Pipeline Products by Territory 12

3.4 Bariatric Surgery Devices-Pipeline Products by Regulatory Path 13

3.5 Bariatric Surgery Devices-Pipeline Products by Estimated Approval Date 14

3.6 Bariatric Surgery Devices-Ongoing Clinical Trials 15

4 Bariatric Surgery Devices-Pipeline Products under Development by Companies 16

4.1 Bariatric Surgery Devices Companies-Pipeline Products by Stage of Development 16

4.2 Bariatric Surgery Devices-Pipeline Products by Stage of Development 18

5 Bariatric Surgery Devices Companies and Product Overview 20

5.1 3DT Holdings LLC Company Overview 20

5.2 Allurion Technologies, Inc. Company Overview 21

5.3 Applied Medical Resources Corporation Company Overview 24

5.4 BAROnova, Inc. Company Overview 25

5.5 BFKW, LLC Company Overview 26

5.6 Boston Scientific Corp Company Overview 27

5.7 C. R. Bard Inc Company Overview 28

5.8 Columbia University Company Overview 29

5.9 EndoRetics Inc. Company Overview 30

5.10 EndoVx Inc Company Overview 31

5.11 Gelesis Inc Company Overview 32

5.12 GI Dynamics Inc Company Overview 34

5.13 Hebrew University of Jerusalem Company Overview 38

5.14 Innovia LLC Company Overview 39

5.15 Johns Hopkins University Company Overview 41

5.16 Mayo Clinic Company Overview 42

5.17 Medi-Globe GmbH Company Overview 43

5.18 MetaModix, Inc Company Overview 44

5.19 Mmtc, Inc. Company Overview 46

5.20 Nanyang Technological University Company Overview 47

5.21 National University of Singapore Company Overview 48

5.22 Precision Medical Devices Inc Company Overview 49

5.23 ReShape Lifesciences Inc Company Overview 50

5.24 Satiety Inc (Inactive) Company Overview 53

5.25 Sensate LLC Company Overview 54

5.26 Silhouette Medical, Inc. Company Overview 55

5.27 SLIMEDICS LTD Company Overview 56

5.28 Spatz FGIA, Inc Company Overview 57

5.29 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 58

5.30 TransEnterix Inc Company Overview 59

5.31 Tulip Medical Ltd. Company Overview 60

5.32 UAS LifeSciences LLC Company Overview 61

5.33 University of Florida Company Overview 62

5.34 University of Miami Company Overview 63

5.35 ValenTx, Inc. Company Overview 64

5.36 Vibrynt, Inc. (Inactive) Company Overview 67

6 Bariatric Surgery Devices- Recent Developments 68

6.1 Jul 17, 2018: BAROnova Announces Submission of Premarket Approval Application to the U.S. FDA for the TransPyloric Shuttle Device Intended for the Treatment of Obesity 68

6.2 Jul 16, 2018: Surefire Medical Names Anil Singhal As Board Director 68

6.3 Jul 04, 2018: NHS EndoBarrier Service Shows Patients Maintain Treatment Effect Six Months Post Explant 69

6.4 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 70

6.5 Jun 27, 2018: ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference 71

6.6 Jun 19, 2018: ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest 71

6.7 Jun 06, 2018: FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon 71

6.8 Jun 05, 2018: Harry Leider, Former Chief Medical Officer of Walgreens, Joins Gelesis as Chief Medical Officer, and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, Joins the Gelesis Board of Directors 72

6.9 Jun 05, 2018: Apollo Endosurgery Announces Presentation of Mayo Clinic's Clinical Study of ORBERA Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis at Digestive Disease Week 2018 73

6.10 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 75

6.11 Jun 04, 2018: Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA Intragastric Balloon System 76

6.12 Jun 04, 2018: Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week 2018 titled: Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon 77

7 Appendix 164

7.1 Methodology 164

7.2 About GlobalData 167

7.3 Contact Us 167

7.4 Disclaimer 167

1.2 List of Figures

Figure 1: Bariatric Surgery Devices-Pipeline Products by Stage of Development 11

Figure 2: Bariatric Surgery Devices-Pipeline Products by Segment 12

Figure 3: Bariatric Surgery Devices-Pipeline Products by Territory 13

Figure 4: Bariatric Surgery Devices-Pipeline Products by Regulatory Path 14

Figure 5: Bariatric Surgery Devices-Pipeline Products by Estimated Approval Date 15

Figure 6: Bariatric Surgery Devices-Ongoing Clinical Trials 16

1.1 List of Tables

Table 1: Bariatric Surgery Devices-Pipeline Products by Stage of Development 11

Table 2: Bariatric Surgery Devices-Pipeline Products by Segment 12

Table 3: Bariatric Surgery Devices-Pipeline Products by Territory 13

Table 4: Bariatric Surgery Devices-Pipeline Products by Regulatory Path 14

Table 5: Bariatric Surgery Devices-Pipeline Products by Estimated Approval Date 15

Table 6: Bariatric Surgery Devices-Ongoing Clinical Trials 16

Table 7: Bariatric Surgery Devices Companies-Pipeline Products by Stage of Development 17

Table 8: Bariatric Surgery Devices-Pipeline Products by Stage of Development 19

Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 10: Gastric Sleeve Magnetic Implant-Product Status 21

Table 11: Gastric Sleeve Magnetic Implant-Product Description 21

Table 12: Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Table 13: Elipse Balloon-Product Status 22

Table 14: Elipse Balloon-Product Description 22

Table 15: Allurion Technologies, Inc.-Ongoing Clinical Trials Overview 23

Table 16: Elipse Balloon-A Randomized, Multi-center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse Gastric Balloon System Versus Sham for the Treatment of Obese Adults 24

Table 17: Elipse Balloon-Pilot Trial of the Elipse Intragastric Balloon System for the Treatment of Overweight and Obese Individuals 24

Table 18: Elipse Balloon-The BALLOON- (Balloon Treatment for Obesity in Norway) Pilot Study 24

Table 19: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 25

Table 20: Next Generation Bariatric Surgical Device-Product Status 25

Table 21: Next Generation Bariatric Surgical Device-Product Description 25

Table 22: BAROnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 23: TransPyloric Shuttle Device-Product Status 26

Table 24: TransPyloric Shuttle Device-Product Description 26

Table 25: BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Table 26: Full Sense-Product Status 27

Table 27: Full Sense-Product Description 27

Table 28: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28

Table 29: TERIS-Product Status 28

Table 30: TERIS-Product Description 28

Table 31: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 32: Restore Suturing System-Product Status 29

Table 33: Restore Suturing System-Product Description 29

Table 34: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 30

Table 35: Gastric Bypass Shunt-Product Status 30

Table 36: Gastric Bypass Shunt-Product Description 30

Table 37: EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 38: Endoretics Device-Product Status 31

Table 39: Endoretics Device-Product Description 31

Table 40: EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 41: EndoVx Device-Product Status 32

Table 42: EndoVx Device-Product Description 32

Table 43: Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 44: Gelesis100-Product Status 33

Table 45: Gelesis100-Product Description 33

Table 46: Gelesis100-Pediatric-Product Status 34

Table 47: Gelesis100-Pediatric-Product Description 34

Table 48: GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Table 49: EndoBarrier Flow Restrictor-Product Status 35

Table 50: EndoBarrier Flow Restrictor-Product Description 35

Table 51: EndoBarrier Liner With EndoBarrier Restrictor-Product Status 36

Table 52: EndoBarrier Liner With EndoBarrier Restrictor-Product Description 36

Table 53: GI Dynamics Inc-Ongoing Clinical Trials Overview 37

Table 54: EndoBarrier Liner With EndoBarrier Restrictor-Endoscopic Treatment of Obesity with a Duodenal-jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss 38

Table 55: EndoBarrier Liner With EndoBarrier Restrictor-Randomization to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity) 38

Table 56: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 39

Table 57: MetaboShield-Product Status 39

Table 58: MetaboShield-Product Description 39

Table 59: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 40

Table 60: Gastric Balloon-Product Status 40

Table 61: Gastric Balloon-Product Description 40

Table 62: Gastric Sleeve-Product Status 41

Table 63: Gastric Sleeve-Product Description 41

Table 64: Laparoscopic Band-Product Status 41

Table 65: Laparoscopic Band-Product Description 41

Table 66: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 42

Table 67: Image-guided Bariatric Arterial Embolization Device-Product Status 42

Table 68: Image-guided Bariatric Arterial Embolization Device-Product Description 42

Table 69: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 43

Table 70: Endoscopic Therapy Device-Obesity-Product Status 43

Table 71: Endoscopic Therapy Device-Obesity-Product Description 43

Table 72: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 44

Table 73: Medi-Globe Gastric Balloon-Product Status 44

Table 74: Medi-Globe Gastric Balloon-Product Description 44

Table 75: MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 76: Endosleeve-Product Status 45

Table 77: Endosleeve-Product Description 45

Table 78: Second Generation Liner Device-Product Status 46

Table 79: Second Generation Liner Device-Product Description 46

Table 80: Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Table 81: Wearable BAT Monitor-Product Status 47

Table 82: Wearable BAT Monitor-Product Description 47

Table 83: Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 48

Table 84: Gastric Clip-Product Status 48

Table 85: Gastric Clip-Product Description 48

Table 86: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 49

Table 87: Weight Management Device-Product Status 49

Table 88: Weight Management Device-Product Description 49

Table 89: Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Table 90: Flow Control Device-Obesity-Product Status 50

Table 91: Flow Control Device-Obesity-Product Description 50

Table 92: ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Table 93: ReShape Vest-Product Status 51

Table 94: ReShape Vest-Product Description 51

Table 95: ReShape Lifesciences Inc-Ongoing Clinical Trials Overview 52

Table 96: ReShape Vest-Safety and Performance Study for the Gastric Vest System: Gastric Vest CE Mark trial 53

Table 97: Satiety Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54

Table 98: TOGA System-Product Status 54

Table 99: TOGA System-Product Description 54

Table 100: Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview 55

Table 101: Sensate Anchored Gastric Device-Product Status 55

Table 102: Sensate Anchored Gastric Device-Product Description 55

Table 103: Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

Table 104: nObese Device-Product Status 56

Table 105: nObese Device-Product Description 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

3DT Holdings LLC

Allurion Technologies, Inc.

Applied Medical Resources Corporation

BAROnova, Inc.

BFKW, LLC

Boston Scientific Corp

C. R. Bard Inc

Columbia University

EndoRetics Inc.

EndoVx Inc

Gelesis Inc

GI Dynamics Inc

Hebrew University of Jerusalem

Innovia LLC

Johns Hopkins University

Mayo Clinic

Medi-Globe GmbH

MetaModix, Inc

Mmtc, Inc.

Nanyang Technological University

National University of Singapore

Precision Medical Devices Inc

ReShape Lifesciences Inc

Satiety Inc

Sensate LLC

Silhouette Medical, Inc.

SLIMEDICS LTD

Spatz FGIA, Inc

The Sheikh Zayed Institute for Pediatric Surgical Innovation

TransEnterix Inc

Tulip Medical Ltd.

UAS LifeSciences LLC

University of Florida

University of Miami

ValenTx, Inc.

Vibrynt, Inc.

3DT Holdings LLC, Gastric Sleeve Magnetic Implant; Allurion Technologies, Inc., Elipse Balloon; Applied Medical Resources Corporation, Next Generation Bariatric Surgical Device; BAROnova, Inc., TransPyloric Shuttle Device; BFKW, LLC, Full Sense; Boston Scientific Corp, TERIS; C. R. Bard Inc, Restore Suturing System; Columbia University, Gastric Bypass Shunt; EndoRetics Inc., Endoretics Device; EndoVx Inc, EndoVx Device; Gelesis Inc, Gelesis100; Gelesis Inc, Gelesis100 - Pediatric; GI Dynamics Inc, EndoBarrier Flow Restrictor; GI Dynamics Inc, EndoBarrier Liner With EndoBarrier Restrictor; Hebrew University of Jerusalem, MetaboShield; Innovia LLC, Gastric Balloon; Innovia LLC, Gastric Sleeve; Innovia LLC, Laparoscopic Band; Johns Hopkins University, Image-guided Bariatric Arterial Embolization Device; Mayo Clinic, Endoscopic Therapy Device - Obesity; Medi-Globe GmbH, Medi-Globe Gastric Balloon; MetaModix, Inc, Endosleeve; MetaModix, Inc, Second Generation Liner Device; Mmtc, Inc., Wearable BAT Monitor; Nanyang Technological University, Gastric Clip; National University of Singapore, Weight Management Device; Precision Medical Devices Inc, Flow Control Device - Obesity; ReShape Lifesciences Inc, ReShape Vest; Satiety Inc (Inactive), TOGA System; Sensate LLC, Sensate Anchored Gastric Device; Silhouette Medical, Inc., nObese Device; SLIMEDICS LTD, Intra Gastric Implant; Spatz FGIA, Inc, Spatz3 Adjustable Balloon System; The Sheikh Zayed Institute for Pediatric Surgical Innovation, Obesity Balloon; TransEnterix Inc, Intraluminal Gastroplasty Device - Obesity; Tulip Medical Ltd., Tulip Capsule; UAS LifeSciences LLC, Ingestible Gastrointestinal Sampling Device; University of Florida, Mutated Gene Repair System; University of Miami, EEA Anvil Placement Device; ValenTx, Inc., ValenTx Endoluminal Bypass System; Vibrynt, Inc. (Inactive), PREVAIL Implant System

select a license
Single User License
USD 4000 INR 290200
Site License
USD 8000 INR 580400
Corporate User License
USD 12000 INR 870600

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com